IPAR INTERPARFUMS INC

8-K Current Report
Filed: February 24, 2026
Health Care
Perfumes, Cosmetics & Other Toilet Preparations

INTERPARFUMS INC (IPAR) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
3 items

  • Item 2.02: Results of Operations and Financial Condition
  • Item 7.01: Regulation FD Disclosure
  • Item 8.01: Other Events

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • Q4 and full-year 2025 results reported; period ending December 31, 2025
  • Filing references press release exhibit containing income statement and balance sheet tables — key financials found there
+2 more insights

Item 7.01 · Regulation FD Disclosure

  • Guess license extended 15 years — signals long-term brand commitment and revenue visibility amid near-term fragrance market volatility
  • 2026 guidance issued (specifics in exhibit); management signals "cautious optimism" for 2026 with more favorable operating environment expected in 2027
+3 more insights

Item 8.01 · Other Events

  • IPAR references existing cash dividend policy disclosures (paragraphs 20–21) as material — signals dividend continuity or potential change worth tracking
  • No new dividend amount or timing disclosed in this item; investor should cross-reference the full filing for specific payout figures

Get deeper insights on INTERPARFUMS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.